Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis

被引:47
|
作者
Woodcock, Ashley [1 ]
Janson, Christer [2 ]
Rees, Jamie [3 ]
Frith, Lucy [3 ]
Lofdahl, Magnus [4 ]
Moore, Alison [5 ]
Hedberg, Martin [6 ]
Leather, David [5 ]
机构
[1] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England
[2] Uppsala Univ, Dept Med Sci Resp, Uppsala, Sweden
[3] GlaxoSmithKline R&D, Biostat, Brentford, England
[4] GlaxoSmithKline, Solna, Sweden
[5] GlaxoSmithKline R&D, Resp Therapy Area, Brentford, England
[6] Polyfuture Inst SWC AB, Nacka, Sweden
关键词
asthma; inhaler devices; OBSTRUCTIVE PULMONARY-DISEASE; OPEN-LABEL;
D O I
10.1136/thoraxjnl-2021-218088
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Objective To compare the effects of switching from a pressurised metered dose inhaler (pMDI)-based to a dry powder inhaler (DPI)-based maintenance therapy versus continued usual care on greenhouse gas emissions (carbon dioxide equivalents, CO(2)e) and asthma control. ethods This post-hoc analysis was based on a subset of 2236 (53%) patients from the Salford Lung Study in Asthma who at baseline were using a pMDI-based controller therapy. During the study patients were randomised to fluticasone furoate/vilanterol (FF/VI) via the ELLIPTA DPI (switched from pMDI to DPI) (n=1081) or continued their usual care treatment (n=1155), and were managed in conditions close to everyday clinical practice. Annual CO(2)e (kg) was calculated for the total number of maintenance and rescue inhalers prescribed. Asthma control was assessed by the proportion of ACT responders (composite of ACT total score >= 20 and/or increase from baseline >= 3). Results The groups were well matched for demographic characteristics and baseline Asthma Control Test (ACT) total score (mean age: 49 years; mean ACT score: usual care, 16.6; FF/VI, 16.5). Annual CO(2)e kg per patient (maintenance plus rescue therapy) was significantly lower with FF/VI DPI treatment ('switch' group) than usual care (least squares geometric mean 108 kg (95% CI 102 to 114) vs 240 kg (95% CI 229 to 252), p<0.001). Asthma control was consistently superior over the 12 months in the FF/VI DPI group compared with usual care. Conclusions Patients switching from a pMDI-based to a DPI-based maintenance therapy more than halved their inhaler carbon footprint without loss of asthma control. The remaining inhaler carbon footprint could be reduced through switches from pMDI to DPI rescue medications or alternative lower-carbon footprint rescue inhalers if available. Asthma control improved in both groups, with greater control demonstrated in those initiated on FF/VI DPI.
引用
收藏
页码:1187 / 1192
页数:6
相关论文
共 50 条
  • [21] SIMULATION OF THE DOSE FROM A DRY POWDER INHALER
    Thalberg, Kyrre
    Remmelgas, Johan
    Duy Nguyen
    Bjorn, Ingela Niklasson
    Wachem, Berend Vad
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2018, 31 (02) : A22 - A22
  • [22] Handling of inhaler devices in actual pulmonary practice: Metered-dose inhaler versus dry powder inhalers
    Khassawneh, Basheer Y.
    Al-Ali, Musa K.
    Alzoubi, Karem H.
    Batarseh, Morad Z.
    Al-Safi, Saafan A.
    Sharara, Abdelmonem M.
    Alnasr, Hatem M.
    RESPIRATORY CARE, 2008, 53 (03) : 324 - 328
  • [23] COMPARISON OF INHALED TERBUTALINE ADMINISTERED BY EITHER THE TURBUHALER DRY POWDER INHALER OR A METERED-DOSE INHALER WITH SPACER IN PRESCHOOL-CHILDREN WITH ASTHMA
    LABERGE, S
    SPIER, S
    DRBLIK, SP
    TURGEON, JP
    JOURNAL OF PEDIATRICS, 1994, 124 (05): : 815 - 817
  • [24] EFFECT OF A VOLUMATIC SPACER AND MOUTH RINSING ON SYSTEMIC ABSORPTION OF INHALED CORTICOSTEROIDS FROM A METERED DOSE INHALER AND DRY POWDER INHALER
    SELROOS, O
    HALME, M
    THORAX, 1991, 46 (12) : 891 - 894
  • [25] Efficacy and tolerability of beclomethasone dipropionate delivered by a novel multidose dry powder inhaler (Clickhaler®) versus a metered-dose inhaler in children with asthma
    Adler, LM
    Anand, C
    Wright, FGD
    Barrett, CF
    McKeith, D
    Clark, WIC
    Maksimczyk, P
    Martin, GDR
    McKinnon, C
    Raffles, AKM
    Buck, H
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2001, 62 (11): : 758 - 769
  • [26] CUMULATIVE DOSE COMPARISON OF THE EFFICACY AND SAFETY OF ALBUTEROL-MULTIDOSE DRY POWDER INHALER AND ALBUTEROL-HYDROFLUOROALKANE METERED DOSE INHALER IN ADULTS WITH ASTHMA.
    Miller, D.
    Wayne, D.
    Ferro, T.
    Taveras, H.
    Iverson, H.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (05) : A46 - A46
  • [27] Deposition of corticosteroid aerosol in the human lung by Respimat® Soft Mist™ Inhaler compared to deposition by metered dose inhaler or by Turbuhaler® dry powder inhaler
    Pitcairn, G
    Reader, S
    Pavia, D
    Newman, S
    JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 2005, 18 (03): : 264 - 272
  • [28] Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler
    Kemp, JP
    Hill, MR
    Vaughan, LM
    Meltzer, EO
    Welch, MJ
    Ostrom, NK
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1997, 79 (04) : 322 - 326
  • [29] Evaluation of a novel salbutamol dry powder inhaler: Clinical equivalence to a standard metered dose inhaler and in-use stability
    Morice, AH
    Peake, MD
    Allen, MB
    Campbell, JH
    ParryBillings, M
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 42 (05) : P658 - P658
  • [30] Relative bioavailability of salbutamol to the lung following inhalation via a novel dry powder inhaler and a standard metered dose inhaler
    Hindle, M
    Peers, EM
    ParryBillings, M
    Chrystyn, H
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 43 (03) : 336 - 338